MENRIUM 10-4 Drug Patent Profile
✉ Email this page to a colleague
When do Menrium 10-4 patents expire, and what generic alternatives are available?
Menrium 10-4 is a drug marketed by Roche and is included in one NDA.
The generic ingredient in MENRIUM 10-4 is chlordiazepoxide; estrogens, esterified. There is one drug master file entry for this compound. Additional details are available on the chlordiazepoxide; estrogens, esterified profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MENRIUM 10-4?
- What are the global sales for MENRIUM 10-4?
- What is Average Wholesale Price for MENRIUM 10-4?
Summary for MENRIUM 10-4
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| DailyMed Link: | MENRIUM 10-4 at DailyMed |
US Patents and Regulatory Information for MENRIUM 10-4
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | MENRIUM 10-4 | chlordiazepoxide; estrogens, esterified | TABLET;ORAL | 014740-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MENRIUM 10-4
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Roche | MENRIUM 10-4 | chlordiazepoxide; estrogens, esterified | TABLET;ORAL | 014740-006 | Approved Prior to Jan 1, 1982 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
